Who founded Matrisome Bio?

Matrisome Bio was founded by Noor Jailkhani, Richard Hynes, Sangeeta Bhatia.

Who are Matrisome Bio's investors?

Matrisome Bio's investors include Bold Capital Partners, The Engine Ventures.

Matrisome Bio

10 employees on LinkedIn · 2 known investors

Find your way into Matrisome Bio

1,063 people in our graph share verified history with the Matrisome Bio team — schools, employers, funds. One of them is your warm intro.

John Kimunlockedknows Sangeeta N. Bhatia · together at Brown University (overlapped)

×5knows the team · via Brown University

×6knows the team · via Massachusetts Institute of Technology

Matrisome Bio is an oncology biotech developing therapies based on extracellular matrix (ECM) biology, using a protein engineering platform to target the tumor microenvironment. Its work spans multiple modalities including radioligand therapies.

Biotech Deep Tech Healthtech

Founders & leadership

Noor JailkhaniinCo-Founder and CEO

Richard HynesCo-Founder / Professor, MIT & HHMI

Sangeeta Bhatia in 𝕏Co-Founder / Professor, MIT & HHMIVenture Partner at Catalio Capital Management, LP

Monica GostissainChief Science Officer

Edward Tad StewartinChief Business Officer

Investors · 2

Bold Capital PartnersSanta Monica

The Engine VenturesCambridge

Frequently asked questions

What does Matrisome Bio do?: Matrisome Bio is an oncology biotech developing therapies based on extracellular matrix (ECM) biology, using a protein engineering platform to target the tumor microenvironment. Its work spans multiple modalities including radioligand therapies.
Who founded Matrisome Bio?: Matrisome Bio was founded by Noor Jailkhani, Richard Hynes, Sangeeta Bhatia.
Who are Matrisome Bio's investors?: Matrisome Bio's investors include Bold Capital Partners, The Engine Ventures.